Learn / ORKA
NASDAQ: ORKA
Oruka Therapeutics (ORKA) stock, explained like you're 5
Oruka Therapeutics trades on the Nasdaq under the ticker ORKA. It is a mid cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.
- Ticker
- ORKA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Size
- Mid cap, about 5.4 billion dollars
Is Oruka Therapeutics a small, medium or large cap company?
No. Oruka Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Oruka Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ORKA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Oruka Therapeutics: The Psoriasis Market Becoming A Barbell, And ORKA 001 Owns The Far End (Seeking Alpha)
- Avoiding Lag: Real Time Signals in (ORKA) Movement (Stock Traders Daily)
- ORKA Nov 2026 95.000 call (ORKA261120C00095000) interactive stock chart (Yahoo Finance UK)
- A proposed 21,000 share sale at Oruka Therapeutics (ORKA) involves officer Joana Goncalves. (Stock Titan)
- Oruka Therapeutics CMO Joana Goncalves sells $523,647 in stock (Investing.com)
Follow ORKA in your daily brief
Each trading day at 5 PM ET we post what happened to Oruka Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ORKA
Questions about Oruka Therapeutics stock
What does Oruka Therapeutics do?
Oruka Therapeutics trades on the Nasdaq under the ticker ORKA. It is a mid cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 5.4 billion dollars.
What is the ticker symbol for Oruka Therapeutics?
Oruka Therapeutics trades under the ticker ORKA on the Nasdaq.
What is Oruka Therapeutics's market cap?
Oruka Therapeutics is a mid cap stock with a market cap of about 5.4 billion dollars.
How does Oruka Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ORKA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ORKA stock every day?
Add ORKA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.